Reversible hypopigmentation with pazopanib
Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2018-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=4;spage=519;epage=520;aulast=Srinivasa |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849324543564316672 |
|---|---|
| author | B J Srinivasa Bhanu Prakash Lalkota Pramod S Chindar Radheshyam Naik |
| author_facet | B J Srinivasa Bhanu Prakash Lalkota Pramod S Chindar Radheshyam Naik |
| author_sort | B J Srinivasa |
| collection | DOAJ |
| description | Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance. |
| format | Article |
| id | doaj-art-8dc1cfda48504ada931a3470c080e926 |
| institution | Kabale University |
| issn | 0971-5851 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-8dc1cfda48504ada931a3470c080e9262025-08-20T03:48:41ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512018-01-0139451952010.4103/ijmpo.ijmpo_104_17Reversible hypopigmentation with pazopanibB J SrinivasaBhanu Prakash LalkotaPramod S ChindarRadheshyam NaikTablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma. Patient did not have any clinical symptoms except for cosmetic significance.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=4;spage=519;epage=520;aulast=SrinivasaPazopanibhypopigmentationreversibletyrosine kinase inhibitor |
| spellingShingle | B J Srinivasa Bhanu Prakash Lalkota Pramod S Chindar Radheshyam Naik Reversible hypopigmentation with pazopanib Indian Journal of Medical and Paediatric Oncology Pazopanib hypopigmentation reversible tyrosine kinase inhibitor |
| title | Reversible hypopigmentation with pazopanib |
| title_full | Reversible hypopigmentation with pazopanib |
| title_fullStr | Reversible hypopigmentation with pazopanib |
| title_full_unstemmed | Reversible hypopigmentation with pazopanib |
| title_short | Reversible hypopigmentation with pazopanib |
| title_sort | reversible hypopigmentation with pazopanib |
| topic | Pazopanib hypopigmentation reversible tyrosine kinase inhibitor |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2018;volume=39;issue=4;spage=519;epage=520;aulast=Srinivasa |
| work_keys_str_mv | AT bjsrinivasa reversiblehypopigmentationwithpazopanib AT bhanuprakashlalkota reversiblehypopigmentationwithpazopanib AT pramodschindar reversiblehypopigmentationwithpazopanib AT radheshyamnaik reversiblehypopigmentationwithpazopanib |